Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
Aspargo Labs develops and commercializes therapeutic agents, handling drug development and regulatory submissions to agencies including the FDA, EMA, MHRA, PMDA and Swissmedic. Its team draws on the pharmaceutical, biotechnology, and consumer product industries, with operations across Europe (Spain, Germany, UK and Ireland).
0 investors
0 investors
AssayQuant develops PhosphoSens fluorescent sensor peptide substrates and assay kits that measure kinase and phosphatase activity in real time, along with KinSight lab services for compound potency, selectivity, and mechanism-of-inhibition profiling. Its products and services serve preclinical drug discovery teams working on kinase and phosphatase inhibitors, covering over 500 kinase and 35 phosphatase targets.</parameter> <parameter name="sector_codes">["biotech", "deeptech"]
0 investors
0 investors
AssurTek Surgical develops OsteoSmartSense, an AI-backed system that provides real-time detection of nerves, sinuses, and other vital structures to reduce risks during dental implant surgery. The technology works with any drill and aims to maintain surgical safety boundaries for clinicians performing implant procedures.
0 investors
0 investors
Astound Research monitors federal and non-federal research funding sources and helps academic and lab researchers find, apply for, and secure grants by identifying relevant opportunities, creating required content, and connecting collaborators. It serves scientists and research labs seeking external funding.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Atlee Biotech develops novel treatments for acute disorders. The company focuses on therapeutics aimed at improving health and longevity.
0 investors
0 investors
Atreo builds RTSM (Randomization and Trial Supply Management) software for clinical trial teams in the life sciences industry. Its platform supports study deployment across all trial phases with a focus on agility, quality, and reduced supply management costs.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors